lupin

Lupin India has received the USFDA approval to market its Betamethasone Dipropionate ointment (augmented), in the American market. The corticosteroid drug is prescribed for the […]

Lupin has received USFDA approval for its generic Divalproex Sodium extended-release tablets to market the same in the American market. The drug Divalproex Sodium extended-release […]

Lupin Pharma has received USFDA approval for its Fluoxetine Tablets USP, 10 mg and 20 mg to market the same in US markets. The drug […]

Lupin has received final USFDA approval to market Sildenafil tablets, used in the treatment of erectile dysfunction in USA. The drug is a generic version […]

Lupin has received USFDA approval to market its generic Atorvastatin Calcium tablets, used for lowering cholesterol, in the American market. The product will be made […]

Lupin has received USFDA approval for Methylprednisolone Tablets USP, 2 mg, 4 mg, 8 mg, 16 mg and 32 mg which is a generic version […]

Lupin has received final USFDA approval for Levothyroxine Sodium tablets USP, 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg, […]

Lupin has received USFDA approval to market Lurasidone Hydrochloride tablets in US markets. The drug is used in the treatment of schizophrenia and will be […]

Lupin has received final USFDA approval to market Budesonide Inhalation Suspension single-dose ampoules, used for treating Asthma in the American markets. The drug is a […]